Inventor · disambiguated record
Fabian Model
Also filed as: MODEL FABIAN
14 granted patents·27 pending applications·80 citations·filing 2002–2021
92Inventor score
Top patents by PatentIndex Score
41 records- 0195US7749702B2Methods and nucleic acids for the analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2006·Granted Jul 6, 2010·32 cites·22 claims
- 0289US8900829B2Methods and nucleic acids for analyses of cellular proliferative disordersDISTLER JUERGEN·Filed 2011·Granted Dec 2, 2014·9 cites·8 claims
- 0386US11186879B2Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2019·Granted Nov 30, 2021·1 cites·15 claims
- 0484US9605306B2Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disordersEPIGENOMICS AG·Filed 2014·Granted Mar 28, 2017·3 cites·3 claims
- 0580US10385402B2Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2016·Granted Aug 20, 2019·1 cites·16 claims
- 0679US2022154287A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2021·Application pending·0 cites
- 0778US10731215B2Method for determining the presence or absence of methylation in a sampleBALLHAUSE MATTHIAS·Filed 2006·Granted Aug 4, 2020·4 cites·8 claims
- 0877US8623599B2Method for methylation analysisDEVOS THEO·Filed 2008·Granted Jan 7, 2014·5 cites·6 claims
- 0973US8101359B2Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapyFOEKENS JOHN·Filed 2003·Granted Jan 24, 2012·6 cites·14 claims
- 1072US9017944B2Methods for the prognosis of breast cancerFOEKENS JOHN·Filed 2004·Granted Apr 28, 2015·6 cites·10 claims
- 1171US7972784B2Method for quantification of methylated DNAEPIGENOMICS AG·Filed 2005·Granted Jul 5, 2011·6 cites·21 claims
- 1270US9695478B2Methods and nucleic acids for the analyses of cellular proliferative disordersLOFTON-DAY CATHERINE E·Filed 2010·Granted Jul 4, 2017·1 cites·5 claims
- 1369US7951563B2Methods and nucleic acids for analysis of cellular proliferative disordersEPIGENOMICS AG·Filed 2006·Granted May 31, 2011·1 cites·8 claims
- 1469US7381808B2Method and nucleic acids for the differentiation of prostate tumorsEPIGENOMICS AG·Filed 2002·Granted Jun 3, 2008·5 cites·16 claims
- 1567US2022034910A1Biomarkers in the selection of therapy of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1665US2010203514A1Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disordersSLEDZIEWSKI ANDREW Z·Filed 2007·Application pending·0 cites
- 1765US2015086989A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2014·Application pending·0 cites
- 1864US2009203011A1Methods and nucleic acids for analyses of cell proliferative disordersEPIGENOMICS AG·Filed 2008·Application pending·0 cites
- 1962US9850532B2Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disordersEPIGENOMICS AG·Filed 2016·Granted Dec 26, 2017·0 cites·4 claims
- 2062US2010143902A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2007·Application pending·0 cites
- 2160US2019119760A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2018·Application pending·0 cites
- 2257US2008064029A1Methods and Nucleic Acids for Analyses of Colorectal Cell Proliferative DisordersLOFTON-DAY CATHY·Filed 2004·Application pending·0 cites
- 2354US2010184027A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2007·Application pending·0 cites
- 2454US2017283880A1Methods and nucleic acids for analyses of colorectal cell proliferative disordersEPIGENOMICS AG·Filed 2017·Application pending·0 cites
- 2553US2002192686A1Method for epigenetic feature selectionFiled 2002·Application pending·0 cites
- 2653US2006024684A1Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patientsEPIGENOMICS AG·Filed 2004·Application pending·0 cites
- 2753US2011171637A1Methods and nucleic acids for analyses of cellular proliferative disordersTETZNER REIMO·Filed 2007·Application pending·0 cites
- 2852US2004102905A1Method for epigenetic feature selectionEPIGENOMICS AG·Filed 2003·Application pending·0 cites
- 2951US2016369356A1Methods and nucleic acids for analyses of cell proliferative disordersEPIGENOMICS AG·Filed 2016·Application pending·0 cites
- 3051US2012184455A1Method and Nucleic Acids for the Improved Treatment of Breast Cell Proliferative DisordersFOEKENS JOHN·Filed 2012·Application pending·0 cites
- 3150US2005255467A1Methods and computer program products for the quality control of nucleic acid assayADORJAN PETER·Filed 2003·Application pending·0 cites
- 3249US2016312287A1Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disordersEPIGENOMICS AG·Filed 2015·Application pending·0 cites
- 3348US2009191548A1Methods and nucleic acids for the analysis of gene expression associated with tissue classificationEPIGENOMICS AG·Filed 2006·Application pending·0 cites
- 3446US2009197250A1Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disordersEPIGENOMICS AG·Filed 2005·Application pending·0 cites
- 3546US2005064410A1Method and nucleic acids for the analysis of colon cancerFiled 2002·Application pending·0 cites
- 3645US2004219549A1Methods and nucleic acids for the differentiation of prostate and renal carcinomasDISTLER JURGEN·Filed 2002·Application pending·0 cites
- 3742US2004234973A1Methods and nucleic acids for the analysis of hematopoietic cell proliferative disordersFiled 2002·Application pending·0 cites
- 3839US2013143210A1Method for the prognosis of ovarian carcinomaMODEL FABIAN·Filed 2010·Application pending·0 cites
- 3939US2015268251A1Biomarkers in the selection of therapy of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 4038US2017322225A1Biomarkers and methods of predictionHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 4137US2014065610A1Method for predicting clinical benefit in the treatment of neurodevelopmental, neurological or neuropsychiatric disordersESSIOUX LAURENT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabian Model files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →